⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for myeloid sarcoma

Every month we try and update this database with for myeloid sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Extramedullary Acute Myeloid Leukemia (eAML): Retrospective Single Center Cohort Study, Clinicopathological, Molecular Analysis and Survival OutcomesNCT05057299
Acute Myeloid L...
retrospective d...
18 Years - King Hussein Cancer Center
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood CancersNCT03589729
Acute Myeloid L...
Blast Phase Chr...
Blasts 10 Perce...
High Risk Myelo...
Myeloid Sarcoma
Myeloproliferat...
Philadelphia Ch...
Cladribine
Cytarabine
Dexrazoxane Hyd...
Gemtuzumab Ozog...
Idarubicin
12 Years - M.D. Anderson Cancer Center
Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary InvolvementNCT06111612
Acute Myeloid L...
Myelodysplastic...
Chronic Myelomo...
Myeloid Sarcoma
Extramedullary ...
18 Years - 55 YearsShanghai General Hospital, Shanghai Jiao Tong University School of Medicine
PET-CT in AML for Detection of Extramedullary AML ManifestationsNCT01278069
Newly Diagnosed...
18 Years - 80 YearsTechnische Universität Dresden
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT01371981
Acute Myeloid L...
Leukemia Cutis
Myeloid Neoplas...
Myeloid Sarcoma
Asparaginase
Bortezomib
Cytarabine
Daunorubicin Hy...
Etoposide
Laboratory Biom...
Mitoxantrone Hy...
Pharmacological...
Quality-of-Life...
Questionnaire A...
Sorafenib Tosyl...
- 29 YearsNational Cancer Institute (NCI)
Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior TransplantationNCT02259348
Acute Lymphobla...
Acute Myeloid L...
Myeloid Sarcoma
Chronic Myeloge...
Juvenile Myelom...
Myelodysplastic...
Non-Hodgkin Lym...
Cyclophosphamid...
Fludarabine
G-CSF
Interleukin-2
Melphalan
Thiotepa
Rituximab
Natural killer ...
T-cell depleted...
CD45RA-depleted...
- 21 YearsSt. Jude Children's Research Hospital
Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior TransplantationNCT02790515
Acute Lymphobla...
Acute Myeloid L...
Myeloid Sarcoma
Chronic Myeloid...
Juvenile Myelom...
Myelodysplastic...
Non-Hodgkin Lym...
Anti-thymocyte ...
Blinatumomab
Cyclophosphamid...
Fludarabine
G-CSF
Melphalan
Mesna
Rituximab
Tacrolimus
Thiotepa
HPC,A Infusion
CliniMACS
Sirolimus
- 21 YearsSt. Jude Children's Research Hospital
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood CancersNCT03589729
Acute Myeloid L...
Blast Phase Chr...
Blasts 10 Perce...
High Risk Myelo...
Myeloid Sarcoma
Myeloproliferat...
Philadelphia Ch...
Cladribine
Cytarabine
Dexrazoxane Hyd...
Gemtuzumab Ozog...
Idarubicin
12 Years - M.D. Anderson Cancer Center
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood CancersNCT03589729
Acute Myeloid L...
Blast Phase Chr...
Blasts 10 Perce...
High Risk Myelo...
Myeloid Sarcoma
Myeloproliferat...
Philadelphia Ch...
Cladribine
Cytarabine
Dexrazoxane Hyd...
Gemtuzumab Ozog...
Idarubicin
12 Years - M.D. Anderson Cancer Center
Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid LeukemiaNCT02658487
Acute Myeloid L...
Acute Myeloid L...
Acute Myeloid L...
Myeloid Sarcoma
Secondary Acute...
Therapy-Related...
Therapy-Related...
Cytarabine
Vosaroxin
18 Years - Vanderbilt-Ingram Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: